Company CVAbout Vivanza Biosciences Ltd 
Vivanza Biosciences Ltd
Micro Cap
Miscellaneous
Vivanza Biosciences Ltd (Previously known Ivee Injectaa Limited) was established in March, 1982 as a Private Limited Company and was converted into a Public Limited Company in May, 1992. Head quartered in Gujarat, India, the Company came into existence in April 2016 with the sole aim to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system.
Company Coordinates
Company Details
403 Sarthik 2 Opp Rajpath Club, S G Highway Ahmedabad Gujarat : 380054
Registrar Details
Purva Shareregistry (India) Pvt Ltd , Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E], Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 4.00 Cr
Number of Shares
4 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
31-Mar-2017
4
4.00
1450000
10
Conversion of Warrants
17-Jun-2016
25.5
2.55
2362000
10
Allotment of Equity To Others
17-Jun-2016
25.5
2.55
2362000
10
Allotment of Equity To Others
27-May-2015
1.88
0.19
-3572000
10
Capital Reduction
27-May-2015
1.88
0.19
-3572000
10
Capital Reduction
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Parth Hemant Parikh (19.77%)
Highest Public shareholder
Ashoka Metcast Limited (3.85%)
Individual Investors Holdings
71.21%
Board of Directors
Management
Designation
Remuneration
Hemant Parikh
Director
0
Sunil Shah
Independent Director
0
Avinash G. Bhojwani
Company Sec. & Compli. Officer
4.57 lacs
Apeksha Vyas
Independent Director
0
Jayendra Mehta
Managing Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchase of goods
12.3405
0%
Purchase of goods
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceutical Products - Traded
6.44
100.00%
Pharmaceutical Products - Traded
Stock DNARevenue and Profits:
Net Sales:
2 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
Miscellaneous
INR 9 Cr (Micro Cap)
NA (Loss Making)
28
0.00%
1.23
1.83%
1.87
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
